Cadeler A/S Just Beat Revenue By 61%: Here's What Analysts Think Will Happen Next

Cadeler A/S (OB:CADLR) investors will be delighted, with the company turning in some strong numbers with its latest results. Performance was better than the analysts expected, with revenues of €299m coming in61% ahead of expectations, and statutory earnings per share (EPS) of €0.48 exceeding forecasts by 17%. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the current consensus from Cadeler's six analysts is for revenues of €584.6m in 2025. This would reflect a sizeable 26% increase on its revenue over the past 12 months. Per-share earnings are expected to ascend 13% to €0.75. Before this earnings report, the analysts had been forecasting revenues of €572.2m and earnings per share (EPS) of €0.62 in 2025. So it seems there's been a definite increase in optimism about Cadeler's future following the latest results, with a sizeable expansion in the earnings per share forecasts in particular.

Check out our latest analysis for Cadeler

Althoughthe analysts have upgraded their earnings estimates, there was no change to the consensus price target of kr83.62, suggesting that the forecast performance does not have a long term impact on the company's valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. Currently, the most bullish analyst values Cadeler at kr89.89 per share, while the most bearish prices it at kr79.50. So we wouldn't be assigning too much credibility to analyst price targets in this case, because there are clearly some widely different views on what kind of performance this business can generate. As a result it might not be a great idea to make decisions based on the consensus price target, which is after all just an average of this wide range of estimates.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. We can infer from the latest estimates that forecasts expect a continuation of Cadeler'shistorical trends, as the 58% annualised revenue growth to the end of 2025 is roughly in line with the 49% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 8.3% per year. So although Cadeler is expected to maintain its revenue growth rate, it's definitely expected to grow faster than the wider industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around Cadeler's earnings potential next year. Pleasantly, they also upgraded their revenue estimates, and their forecasts suggest the business is expected to grow faster than the wider industry. The consensus price target held steady at kr83.62, with the latest estimates not enough to have an impact on their price targets.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for Cadeler going out to 2027, and you can see them free on our platform here.

It is also worth noting that we have found 2 warning signs for Cadeler that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.